The healthcare giant's shift in strategy puts an increased focus on systems used by electrophysiologists and interventional cardiologists to manage and treat cardiovascular disease.

The product at the heart of this recall is a dietary supplement taken to boost energy and performance when exercising. The FDA previously warned the public not to take it due to the potential side effects. 

Medtronic is recalling more than 700 OmniaSecure defibrillation leads, urging customers to quarantine and return them. The FDA has ruled this is a Class II recall. No adverse events have been reported.

Newsweek and Statista have shared their 2027 list of the world’s top 300 hospitals for cardiology. Nine of the top 20 are based in the United States.

Medtronic identified an issue with its CareLink SmartSync device manager providing inaccurate longevity estimates for certain leadless pacemakers. Customers can download a software update to resolve the issue going forward.

Children with congenital heart disease outgrow their replacement valves, requiring repeat open-heart surgeries. The Autus can be expanded using a transcatheter procedure.

Abbott's Amplatzer Paraclose PVL Occluder is the first heart device of its kind approved by the FDA to treat paravalvular leak. The agency made its decision after reviewing data from 200 patients who had undergone aortic or mitral valve replacement surgery.

According to Newsweek, 13 of the top 20 hospitals for cardiac surgery in the entire world are located in the United States. The list includes 150 hospitals in total. 

Certain Sapien M3 TMVR delivery systems have been linked to a risk of malfunctioning in a way that puts patients at risk. The devices included in this early alert should be returned to the manufacturer. 

The instructions for Abbott's Amplatzer Amulet Left Atrial Appendage Occluder now include more details about minimizing the risk of pulmonary artery injury. This a Class II recall, but no devices need to be returned.

New codes for these technologies have made a world of difference for clinicians. Reimbursement for the use of AI is an area where cardiology is far ahead of most other healthcare specialties.